Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 10, 2002, Pages 1100-1103

  Terry, Mary Beth ^a,b   Gammon, Marilie D ^d   Schoenberg, Janet B ^e   Brinton, Louise A ^f   Arber, Nadir ^g   Hibshoosh, Hanina ^b,c  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Cancer Epidemiology Services ^*  (United States)

^d IL   (United States)

^e Cancer Epidemiology Services   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; CELL CYCLE PROTEIN; CYCLIN D1; ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; RISK FACTORS;

EID: 0036800670     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994
2. Weinstein, I. B. Relevance of cyclin D1 and other molecular markers to cancer chemoprevention. J. Cell. Biochem. Suppl., 25: 23-28, 1996
3. Lamb, J., Ladha, M. H., McMahon, C., Sutherland, R. L., and Ewen, M. E. Regulation of the functional interaction between cyclin D1 and the estrogen receptor. Mol. Cell Biol., 20: 8667-8675, 2000
4. Zhang, S., Caamano, J., Cooper, F., Guo, X., and Klein-Szanto, A. J. P. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol., 102: 695-698, 1994
5. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M., and Bartek, J. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57: 353-361, 1994
6. Arber, N., Gammon, M. D., Hihshoosh, H., Britton, J. A., Zhang, Y., Schonberg, J. B., Roterdam, H., Fabian, I., Holt, P. R., and Weinstein, I. B. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in the adenocarcinomas of the stomach. Hum. Pathol., 30: 1087-1092, 1999
7. Sutter, T., Doi, S., Carnevale, K. A., Arber, N., and Weinstein, I. B. Expressions of cyclins D1 and E in human colon adenocarcinomas. J. Med., 28: 285-301, 1997
8. Han, E. K. H., Rubin, M. A., Lim, T., Arber, N., Xing, W. Q., and Weinstein, I. B. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate, 35: 95-101, 1998
9. Barnes, D. M. Cyclin D1 in mammary carcinoma. J. Pathol., 181: 267-269, 1997
10. Jiang, W., Kahn, S. M., Zhou, P., Zhang, Y., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M., and Weinstein, I. B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8: 3447-3457, 1993
11. Sicinski, P., and Weinberg, R. A. A specific role for cyclin D1 in mammary gland development. J. Mammary Gland Biol. Neoplasia, 2: 335-342, 1997
12. Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med., 1: 1257-1260, 1995
13. Sutherland, R. L., Hamilton, J. A., Sweeney, K. J. A., Watts, C. K. W., and Musgrove, E. A. Expression and regulation of cyclin genes in breast cancer. Acta Oncol., 34: 651-656, 1995
14. Musgrove, E. A., and Sutherland, R. L. Cell cycle control by steroid hormones. Semin. Cancer Biol., 5: 381-389, 1994
15. Foster, J. S., and Wimalasena, J. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol. Endocrinol., 10: 488-498, 1996
16. Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M. G., Truss, M., Beato, M., Sica, V., Bresciani, F., and Weisz, A. 17β-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene, 12: 2315-2324, 1996
17. Steeg, P. S., and Zhou, Q. Cyclins and breast cancer. Breast Cancer Res. Treat., 52: 17-28, 1998
18. Sutherland, R. L., Prall, O. W., Watts, C. K., and Musgrove, E. A. Estrogen and progestin regulation of cell cycle progression. J. Mammary Gland Biol. Neoplasia, 3: 63-72, 1998
19. Foster, J. S., Henley, D. C., Bukovsky, A., Seth, P., and Wimalasena, J. Multifaceted regulation of cell cycle progression by estrogen L regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol. Cell. Biol., 21: 794-810, 2001
20. Prall, O. W., Rogan, E. M., and Sutherland, R. L. Estrogen regulation of cell cycle progression in breast cancer cells. J. Steroid Biochem. Mol. Biol., 65: 169-174, 1998
21. Watts, C. K. W., Sweeney, K. J. E., Warlters, A., Musgrove, E. A., and Sutherland, R. L. Antiestogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells. Breast Cancer Res. Treat., 31: 95-105, 1994
22. Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., and Weinberg, R. A. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82: 621-630, 1995
23. Schmidt, E. V. Happenstance, circumstance or enemy action: cyclin D1 in breast, eye and brain. Bioessays, 18: 6-8, 1996
24. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. B. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994
25. Brinton, L. A., Daling, J. R., Liff, J. M., Schoenberg, J. B., Malone, K. E., Stanford, J. L., Coates, R. J., Gammon, M. D., Hanson, L., and Hoover, R. N. Oral contraceptives and breast cancer risk among younger women. J. Natl. Cancer Inst., 87: 827-835, 1995
26. Gammon, M. D., Hibshoosh, H., Terry, M. B., Bose, S., Schoenberg, J. B., Brinton, L. A., Bernstein, J. L., and Thompson, W. D. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women. Cancer Epidemiol. Biomark. Prev., 8: 255-263, 1999
27. Waksberg, J. Sampling methods for random digit dialing. J. Am. Stat. Assoc., 73: 40-46, 1978
28. Hosmer, D. W., and Lemeshow, S. Applied Logistic Regression. New York: John Wiley & Sons, 1989, 216-238
29. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53, 297 women with breast cancer and 100, 239 women without breast cancer from 54 epidemiological studies. Lancet, 347: 1713-1727, 1996
30. Gammon, M. D., Hibshnosh, H., Terry, M. B., Bose, S., Schoenberg, J. B., Brinton, L. A., Bernstein, J. L., and Thompson, W. D. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. Cancer Epidemiol. Biomark. Prev., 8: 413-419, 1999
31. Terry, M. B., Gammon, M. D., Ng-Mak, D., and Thompson, W. D. Re: "p53 protein overexpression in relation to risk factors for breast cancer". Am. J. Epidemiol., 147: 511-512, 1998